DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has been selected as digital health provider by Coastal Family Health Center. The center is a nonprofit healthcare network that offers comprehensive primary care to patients in underserved counties in and around the Mississippi Gulf Coast. Initially, Coastal Family Health will utilize Dario’s Remote Patient Monitoring (“RPM”) solution for hypertension and the prevention of related cardiac events. The announcement noted that the center anticipates that its patients will benefit from personalized digital journeys curated and powered by Dario’s next-generation artificial intelligence (“AI”) digital therapeutic tools and quality care, which enable more frequent and meaningful interactions with healthcare providers and improve outcomes by helping them manage their chronic conditions. “Today’s announcement is just the beginning of an exciting set of new business-to-business (‘B2B’) channel clients that we intend to announce over the coming weeks with providers, employers and payers,” said DarioHealth president Rick Anderson in the press release. “We are very pleased to have been selected by Coastal Family Health Center for their digital health needs following a rigorous evaluation process that included many of the major competitors in our industry. We believe our selection by Coastal Family Health Center reflects not only the strength of our RPM capabilities, but also our differentiated ‘customer-first’ approach that allows us to tailor our program to their specific needs while opening up access to healthcare to support patients when and how they need.”
To view the full press release, visit https://ibn.fm/mNrgo
About DarioHealth Corp.
DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario’s next-generation, AI-powered, digital therapeutic solutions support more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users’ health. Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.